What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Gene
The scientist’s investigation covers issues in Photodynamic therapy, Antimicrobial, Microbiology, Photosensitizer and Reactive oxygen species.
His study in Photodynamic therapy is interdisciplinary in nature, drawing from both Cancer, Cancer research, Singlet oxygen, Immunology and Pathology.
His work carried out in the field of Antimicrobial brings together such families of science as Infectious disease and Multiple drug resistance, Antibiotics, Antibiotic resistance, Drug resistance.
The Microbiology study combines topics in areas such as Pseudomonas aeruginosa, Wound healing, In vivo and Staphylococcus aureus.
His research in Photosensitizer intersects with topics in Efflux, Biochemistry, Candida albicans, Rose bengal and Methylene blue.
His Reactive oxygen species research includes elements of Inflammation, Adenosine triphosphate, Membrane potential, Pharmacology and Mitochondrion.
His most cited work include:
- Photodynamic therapy of cancer: An update†‡ (2464 citations)
- Photodynamic therapy of cancer: An update†‡ (2464 citations)
- Photodynamic therapy and anti-tumour immunity (1502 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Photodynamic therapy, Antimicrobial, Microbiology, Photosensitizer and Cancer research.
The various areas that Michael R. Hamblin examines in his Photodynamic therapy study include Singlet oxygen, Reactive oxygen species, Immune system, Pathology and Photochemistry.
His Immune system study combines topics from a wide range of disciplines, such as Cytotoxic T cell and Antigen.
His Antimicrobial study combines topics in areas such as Escherichia coli, Antibiotics, Antibiotic resistance and Candida albicans.
His research in Microbiology tackles topics such as In vivo which are related to areas like In vitro.
His Photosensitizer research incorporates themes from Cationic polymerization and Biochemistry.
He most often published in these fields:
- Photodynamic therapy (43.02%)
- Antimicrobial (23.39%)
- Microbiology (21.63%)
What were the highlights of his more recent work (between 2019-2021)?
- Cancer research (15.34%)
- microRNA (4.06%)
- Nanotechnology (15.18%)
In recent papers he was focusing on the following fields of study:
Michael R. Hamblin mainly investigates Cancer research, microRNA, Nanotechnology, Cancer and Cancer cell.
Michael R. Hamblin has included themes like Wnt signaling pathway, Apoptosis, Immune system, Immunotherapy and Metastasis in his Cancer research study.
His study with Immune system involves better knowledge in Immunology.
His microRNA study integrates concerns from other disciplines, such as Carcinogenesis, Epigenetics, Long non-coding RNA and Bioinformatics.
As a member of one scientific family, he mostly works in the field of Nanotechnology, focusing on Biocompatibility and, on occasion, Graphene and Gene delivery.
Michael R. Hamblin usually deals with Cancer and limits it to topics linked to Clinical trial and Medical physics.
Between 2019 and 2021, his most popular works were:
- COVID-19: Transmission, prevention, and potential therapeutic opportunities. (144 citations)
- The immune system and COVID-19: Friend or foe? (81 citations)
- Circular RNAs and gastrointestinal cancers: Epigenetic regulators with a prognostic and therapeutic role. (70 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
His scientific interests lie mostly in microRNA, Cancer research, Coronavirus disease 2019, Cancer and Nanotechnology.
The study incorporates disciplines such as Receptor, Epigenetics, Bioinformatics and Cell biology in addition to microRNA.
His study in Cancer research is interdisciplinary in nature, drawing from both Autophagy, Apoptosis, Combination therapy and Caspase 8.
His biological study spans a wide range of topics, including Proinflammatory cytokine, Cell binding and 2019-20 coronavirus outbreak.
His research integrates issues of Clinical trial and Photodynamic therapy in his study of Cancer.
His Nanotechnology research is multidisciplinary, incorporating elements of Wound healing and Low dose.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
